Ongoing pandemic, lingering supply chain aftershocks press GPOs, IDNs

“Overall, the healthcare industry needs increased collaboration and a willingness for transparency,” she said. “Supply chain resiliency and supply assurance cannot be achieved with participation from just one or two stakeholders. It requires alignment to data standards and a willingness for two-way transparency across providers, distributors and suppliers. GPOs can facilitate increased transparency, information sharing and enforce data standards.”

Steele acknowledges that providers will pursue product wherever they can when demand spikes. But she argues that one element may surpass diversifying suppliers.

“Providers will always look for alternative suppliers during times of significant supply constraints; however, conservation strategies have certainly risen to the top of the list for mitigating disruption,” she noted. “It’s important that providers employ a strategy that diversifies manufacturing locations, which is not necessarily supplier diversification. Most providers aren’t interested in having multiple suppliers for a particular product. The stress of change management and training is costly. In a crisis, supply availability certainly becomes the priority, but stress on the organization on top of labor shortages must remain top of mind as well.”

The supply chain needs to bend without breaking, according to Cory Turner, CMRP, Senior Director, Healthcare Strategy, Tecsys Inc.

“The fragility of any supply chain lies in how flexible or inflexible it is,” he observed. “If disruptions cause fractures, your supply chain needs to be reimagined, but if the disruptions cause stretch marks, it means you’re doing something right.

“The most probable infrastructure changes among IDNs are that they simply accelerate the diversification strategies that they have already begun,” Turner continued. “In what’s likely a hybrid approach, IDNs ought to consider multiple GPOs combined with self-distribution. This will call for leadership and a maturation of internal sourcing strategy on the IDN side. By employing a diversified approach, IDNs design in more resiliency, which avoids drastic measures like force majeure.”

Think local, Turner encourages.

“A focal point for strategic sourcing, both on the IDN and GPO side, should be to see where they can shorten their supply chains,” he indicated. “That translates to business with more local manufacturers, and possibly investing in vertical integration for better control over certain goods. The fewer the links, the less opportunity for kinks in the chain.”

It may be time to rethink what’s been done before, not necessarily because it backfired during a crisis but that it may not have gone far enough, according to Tom Redding, Senior Managing Director, Healthcare Services, St. Onge Co.

“Over the last decade, there has been a significant push across the industry to streamline the sourcing/contracting through the GPO, which has allowed the health systems to run ‘lean’ on internal teams while reaping the financial benefits,” he observed. “I believe organizations will start to challenge their existing thinking on the use of a GPO and further develop the internal capability to ensure the organization is able to quickly adapt to backorders and supply chain disruptions. I anticipate greater pressure from the GPOs and IDNs on the manufacturers to provide better inventory visibility to ensure the organization has the appropriate amount of supply chain risk. GPOs and IDNs will need to think beyond the ‘price only’ and understand the complete supply chain picture to assess their risk.”

This doesn’t forecast the death of or doubts about GPOs, however.

“We anticipate there will be a slight uptick in ‘inventory buffering’ across health systems as they contend with not having inventory visibility and transparency from the manufacturers,” Redding clarified. “With all of the state mandates on PPE, health systems are starting to understand that managing risk is part of their new reality. Prior to the pandemic, there was an inherent trust that manufacturers had their back and would be ‘ready to serve’ at a moment’s notice. 

“Creating a strategic supply chain master plan is critical to ensure the organization can proactively assess, plan, execute and improve the delivery of its services. We anticipate more attention will be spent to further integrate the entire supply chain from sourcing/contracting through to the delivery of supply chain services to the customers,” he added.

GPOs must remain steadfast in their commitment and partnership with members and continuously innovate to meet goals, according to Jeff Ashkenase, Group Vice President, End-To-End Supply Chain, Nexera, a subsidiary of Premier, Inc.

“In a [crisis] situation like we’ve encountered over the last two years, when demand outpaces supply, GPOs can utilize many of their existing resources – and also must deploy innovative, creative strategies – to help members obtain products in short supply,” Ashkenase said.

Diversifying supply sources is one. “GPOs can help safely accelerate new or alternative supplier entrants and products to the market and can provide these suppliers with information about specs and regulations they need to follow to ensure product quality meets a hospital’s needs. In New York during the spring of 2020, we helped many suppliers ramp up production capabilities for PPE with product that met our members’ needs,” he noted.

Sharing vital information is another. This spans information on a supplier’s current inventory, allocation, delivery plans and future capacity; product information; and conservation and conversion information/support, Ashkenase adds.

Harnessing the power of data is a third. “Underpinning a comprehensive transformational supply chain strategy is leveraging technology and data to better understand risk, provide greater visibility and support continuous operational transformation,” he continued. “This allows healthcare providers the ability to better plan and allocate supplies, as well as fast-track critical products via expedited sourcing agreements.

“COVID-19 made it abundantly clear that we need greater diversity of manufacturing and suppliers, and that includes greater domestic production,” Ashkenase observed. “Today, health system leaders are co-investing in domestic suppliers – and for product categories that lack adequate competition, geographic diversity or stable sources of contingency supply. Through collaborations with Prestige Ameritech, DeRoyal Industries Inc., Honeywell and Exela Pharma Sciences, Premier and its members are producing millions of domestically made PPE and pharmaceutical products. Additionally, innovative direct sourcing and e-commerce capabilities are serving as vital channels to access high-quality PPE and other healthcare supplies that are vetted for high-quality and fair pricing.”

Ash Chawla, RPh, Chairman & CEO, PDM Healthcare, recognizes how COVID-19 has aimed a spotlight on “inherent discord and disruption” in the healthcare supply chain “unlike any other event in the past century.

“This supply chain weakness, coupled with changes in U.S. government and policies, has created an operational crisis for health systems and other healthcare providers,” Chawla said. “Along with meeting the challenges of supply and demand, healthcare supply chains must renew focus on improving capacity and resilience.”  

Healthcare facilities must adapt to the new environment of supply chain disruptions, where at almost any given time their operations and workflow can be significantly impacted, according to Chawla. He counts supply chain optimization as one of most important priorities for any healthcare facility or IDN, after delivering quality patient care and that GPOs should assist in achieving these important objectives.

Chawla calls for infrastructure changes that may include creating systems and protocols to enable adaptability to the dynamically changing pandemic environment.

“Additionally, interoperability improvements can be made to allow for easy and efficient access to centralized, consumable, real-time data across a health system or IDN, thereby making inventory management easier by determining what products are in stock and what products are needed, leading to a greater capability to forecast and meet future demands,” he said.

“GPOs can assist health systems and IDNs in implementing such changes by providing their members with the processes and technologies to improve operability,” Chawla continued. “Many health systems still continue to make purchasing decisions based on legacy systems, past histories or physician preference items in different departments.  These practices can lead to ‘scattered’ purchasing, unnecessary purchases or inability to forecast and acquire the products that are truly needed to maintain operations and patient care in a COVID drive environment.”

GPOs should be functioning as more than just contracting agents, Chawla insists.

“As aggregators of purchasing across their entire membership base, GPOs are able to analyze and forecast purchasing needs across facilities, down to minute details based on size, geographical region and patient base,” he said. “Working with GPOs to forecast need as well as access management tools can enable health systems and IDNs to reduce waste and delayed procedures as well as high inventory and carrying costs.” 

Chawla recommends health systems and IDNs to work with GPOs that provide choice, flexibility and options in purchasing, particularly when specific manufacturers or wholesalers experience a product shortage, inability to supply or any other force majeure event.

Discontinuity frustrations

Hospitals and other healthcare organizations that belong to GPOs and IDNs rely on those entities, by and large, to handle all their contracting needs – from sourcing to negotiations – in effect, outsourcing those traditional supply chain functions to a third party. But when a crisis or disaster hampers, hinders or even prevents those services from being provided as expected, participating healthcare organizations – whether owners, members or affiliates – need to respond as effectively as possible.

Steele recognizes the conundrum that remains ongoing.

“We will never be able to end disruptions,” she noted. “We should, however, be able to reduce the impact they have on operations. When key stakeholders work together quickly to do their part, it takes strain off of the entire value chain.

“At Vizient, we certainly see ourselves as an extension of our members’ supply chain team,” Steele continued. “Our responsibility is to provide supply assurance so Vizient members can count on business continuity. This is why real time supply data and information, alternative strategies, conservation methodologies, committed inventory and teams of subject matter experts are so important. Vizient is committed to providing insights, access, enablement and advocacy for our members to ensure they have all the resources to focus on delivering patient care.”

Healthcare organizations and IDNs must stop placing all their eggs in the same basket, according to Turner, and embrace data standards.

“We have seen more and more hospitals and health systems turn to in-house programs that weave together strategic sourcing, GPOs and consolidated service centers to gain more control of their flow of goods,” he said. “This is especially pertinent in times of crisis. In parallel, IDNs must gain better visibility into the goods that they do have on hand to make sure everything is being used in a timely and effective manner. Paired with point-of-use and central stores supply chain management, data standards can go a long way in improving inventory management, increased patient safety and driving better outcomes.”

Redding calls for more transparency in the marketplace now more than ever.

“Creating transparency between the member hospitals and GPO or IDN will ensure the members have a clear understanding of what to expect during times of supply chain disruption,” he said. “IDNs will need to take a more hands-on approach to managing the entire supply chain and integrating the supply chain operations teams into the conversation to ensure there is transparency on how supply chain risk is being mitigated. Too many times, the supply chain operations team is not clear on their options for product substitution which leads to delays and potential risk for the organization and patient.

“GPOs and IDNs will need to think more strategically on what products have the greatest organizational risk and develop a clear and transparent plan on how to mitigate the risk effectively,” he added. “In some cases, it is building more inventory within their systems, other times, it is developing a sourcing strategy to mitigate a potential disruption.”

Pandemic notwithstanding, hospitals and their supply chain teams know they must do more with less, according to Ashkenase.

“A true GPO partner will act as a vital extension of a member’s internal team – bringing forward innovative strategies to mitigate disruptions as well as solutions that enable product access, efficiencies and value long-term. This allows supply chain teams and providers at large to focus on what they do best – deliver high-quality patient care,” he said.

“Throughout the pandemic, members have looked to us to vet and identify new or alternative suppliers, and leverage scale and commitment to bolster domestic and diverse production,” Ashkenase continued. “We’ve worked with members to share conservation guidance and review product specifications to ensure quality and safety. We’re also equipping providers across the nation with more sophisticated product burn data, visibility into manufacturer inventory status and prospects.”

One example involves Premier’s syndromic surveillance technology that leverages [artificial intelligence] and machine learning to track disease symptoms and enable communities to predict hospital utilization, geographic surges and associated resources, according to Ashkenase. “We are working with coalitions of providers in various states to deploy this technology, which is critical to both our continued management of COVID-19 disease spread as well as streamlining the prior authorization process and improving health system performance overall,” he added.

Ashkenase indicates that provider members are looking beyond contracting and product access strategies to collaborate on education and information/best practice sharing – both from Nexera and Premier experts and among their peers at healthcare organizations across the country.

“I, personally, never want to see another scenario where healthcare providers can’t get access to the vital supplies needed to protect their workers and care for patients,” he asserted. “A primary focus for us has, and will continue to be, innovative strategies and creative partnerships that lower barriers to entry and drive stable supply.

“And I believe Nexera’s perspective is truly unique given our work over the last two years. Our GPO and embedded resources help members manage their supply chains on a on day-to-day basis,” he added. “We have the manufacturing perspective through S25 Global and Premier’s domestic investments alongside members. We worked with New York City officials to determine the appropriate strategy for their stockpiling of supplies. We’re coordinating across the industry to help solve the supply chain challenges presented by COVID-19, partnering with providers, GPOs, distributors, manufacturers and the government. Because of this, we’ve developed solutions to better prepare our members moving forward.”

Chawla emphasizes that for healthcare facilities to remain viable, they must have access to products, services or technologies that continuously meet their needs without disruption. “Regardless of whether a facility is owned by a GPO or IDN, it must have oversight over its own purchasing needs and the ability to look outside its traditional ownership and protocol for other purchasing options if the status quo does is not able to meet its needs.”